Have a personal or library account? Click to login
Fmoc solid-phase synthesis of RF9 optimization with mass spectrometry verification Cover

Fmoc solid-phase synthesis of RF9 optimization with mass spectrometry verification

Current Issues in Pharmacy and Medical Sciences
Volume 35 (2022): Issue 1 (July 2022)
By: Marta Orocz,  Kinga Hartman,  Marek Smoluch,  Jerzy Silberring and  Przemyslaw Mielczarek  
Open Access
|Jul 2022

Authors

Marta Orocz

Department of Analytical Chemistry and Biochemistry, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Krakow, Poland

Kinga Hartman

Department of Analytical Chemistry and Biochemistry, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Krakow, Poland

Marek Smoluch

Department of Analytical Chemistry and Biochemistry, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Krakow, Poland

Jerzy Silberring

Department of Analytical Chemistry and Biochemistry, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Krakow, Poland

Przemyslaw Mielczarek

mielczar@if-pan.krakow.pl

Laboratory of Proteomics and Mass Spectrometry, Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
DOI: https://doi.org/10.2478/cipms-2022-0003 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 11 - 15
Submitted on: Sep 7, 2021
|
Accepted on: Jun 6, 2022
|
Published on: Jul 28, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
RF9,
COMU,
mass spectrometry,
solid-phase synthesis,
1-adamantanecarboxylic acid
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2022 Marta Orocz, Kinga Hartman, Marek Smoluch, Jerzy Silberring, Przemyslaw Mielczarek, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 35 (2022): Issue 1 (July 2022)Next article